[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases. This new approval is found under the brand name
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system. This new approval is Renflexis
[ad_1] Biologic treatments for inflammatory bowel diseases may help heal the intestines, a new study found. [ad_2] Source link
